INVEGA SUSTENNA 150 mg Prolonged Release Suspension for Intramuscular Injection

Manufacturer
JANSSEN PHARMACEUTICA N.V.
 
Contents
Paliperidone
 
Indication
Schizophrenia
 
Instruction
Administer via IM.
 
Drug interaction
Centrally acting drugs & alcohol; l-dopa & other dopamine agonists; carbamazepine; divalproex Na